Business Wire

DNA Script Obtains CE Mark for SYNTAX DNA Printing Platform

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the first EDS-powered benchtop DNA printer.
Business Wire

French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR assays using primers and ...
Business Insider

DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis

The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...
Business Insider

DNA Script Joins GE Research Collaboration to Develop On-Demand Vaccines and Therapeutics in Response to Biothreats for DARPA NOW Project

DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script has been ...
BioWorld

DNA Script adds new investors to close out $200M series C round

DNA Script SAS is closing a $200 million series C fundraising round, with new investors pumping in cash to push commercialization of its DNA printing platform Syntax. The company has raised a total of ...